Altisource Announces First Quarter 2024 Financial Results
April 25, 2024 07:06 ET
|
Altisource Portfolio Solutions S.A.
LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage...
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
April 25, 2024 07:01 ET
|
HOOKIPA Pharma Inc.
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback ...
Nasdaq Announces 9% Increase in Quarterly Dividend to $0.24 Per Share
April 25, 2024 07:01 ET
|
Nasdaq, Inc.
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.24 per share on the company's outstanding common...
Valley National Bancorp Announces First Quarter 2024 Results
April 25, 2024 07:00 ET
|
Valley National Bank
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the first quarter 2024 of $96.3...
Climb Channel Solutions Launches Partnership with Automox, Providing Leading Endpoint Management Solution to North American Partners
April 25, 2024 07:00 ET
|
Climb Channel Solutions
EATONTOWN, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:...
First Northwest Bancorp Reports First Quarter 2024 Financial Results
April 25, 2024 07:00 ET
|
First Northwest Bancorp
First Northwest Bancorp Reports First Quarter 2024 Financial Results
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
April 25, 2024 07:00 ET
|
Purple Biotech Ltd.
Interim data suggests reduced risk of progression or death in the CM24/nivolumab plus standard of care Nal-IRI/5FU/LV arm of the study REHOVOT, Israel, April 25, 2024 (GLOBE NEWSWIRE) --...
American Airlines Reports First-Quarter 2024 Financial Results
April 25, 2024 07:00 ET
|
American Airlines, Inc.
FORT WORTH, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) today reported its first-quarter 2024 financial results, including: Record first-quarter revenue of...
Stericycle, Inc. Reports Results For The First Quarter 2024
April 25, 2024 07:00 ET
|
Stericycle, Inc.
BANNOCKBURN, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2024. Revenues for the first quarter were...
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
April 25, 2024 07:00 ET
|
Optinose, Inc.
YARDLEY, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...